Contraception
First Line Drugs
- PLAN B (G03AC03)
- DOM-MEDROXYPROGESTERONE 10MG (G03DA02)
- NORGESTREL/ETHINYL ESTSRADIOL ()
Second Line Drugs
- MICRONOR TABLETS 28-DAY (G03AC01)
Reference
Comments/Instructions
1. Prophylaxis
i. Oral contraception combination (estrogen and progestin). See chart in Contraception, oral - combination therapy.
OR
ii. Levonorgestrel implant 6 x 36 mg capsules; replace every 5 years $450.00/kit
OR
iii. Intramuscular progesterone
medroxyprogesterone 150 mg IM, every 3 months $13.96/3 months
OR
iv. Intrauterine devices (IUDs)
progesterone device replace annually $25-50 (approx.)
or copper device replace every 2 years $25-50 (approx.)
OR
2. Barrier contraception
Six methods of contraception used only during coitus: spermicide, male condoms, female condoms, sponges, diaphragms and cervical caps. The last two methods require an office visit for fitting.
i. Post-coital
norgestrel/ethinyl estradiol 1.0 mg/100 µg (2 tablets) as soon as possible after intercourse and 2 tablets 12 h later $11.55/pkg
Second-line therapies:
Prophylaxis
Oral contraception, progestin
norethindrone 0.35 mg $12.21/month
Additional instructions and notes
-Approximate failure rates for the various methods in actual use are: levonorgestrel implant 0.09%; intramuscular progesterone 0.3%; copper IUD 0.8%; progesterone IUD 2%; oral contraceptives (all types) 3%; condom 12%; diaphragm 18%; cervical cap 18%; spermicides 21%; female condom 21%; sponge 24%.
-Oral contraceptives containing only progestin have a higher failure rate.
-Candidates for progestin-only contraceptives are women who have hypertension, migraine headaches or cardiovascular risk factors that are relative contraindications to the use of combined oral contraceptives.
-To minimize the risk of adverse cardiovascular effects, prescribe oral contraceptives containing 35 µg of estrogen or less and a low dose of a progestin.
-Patients considered for IUDs should be parous, monogamous women, who are not at increased risk for pelvic inflammatory disease.
-Natural family planning has a high failure rate, is time consuming and offers no protection against sexually transmitted diseases.
-Begin postcoital therapy within 72 h of intercourse after establishing the absence of pre-existing pregnancy.
-Anti-emetics should be used in conjunction with postcoital therapy.
-Patients should have a pregnancy test 1 week after postcoital therapy.
-The failure rate for postcoital therapy is about 25%.
Tags
- Obstetrics and Gynecology

No comments so far